🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT05731024
Recruiting Not applicable

Closed-loop Synchronization Versus Conventional Synchronization

NCT05731024 · tracked via the Priya Life Science Turkey tracker
Sponsor
Dr. Behcet Uz Children's Hospital
Phase
Not applicable
Started
2023-02-06
Last updated
2025-03-19

Condition(s) studied

Acute Respiratory FailurePediatric Respiratory Distress Syndrome

Investigational drug(s) / intervention(s)

close-loop synchronization controller with SPONT modeConventional synchronization settings with SPONT mode

close-loop synchronization controller with SPONT mode: One-hour period where the pressure support of spontaneous breath will be automatically titrated based on pressure and flow waveform analysis obtained from the patient.

Conventional synchronization settings with SPONT mode: One-hour period where the pressure support of spontaneous breath will be manually set.

Study summary

A prior research indicated that asynchrony between the patient and ventilator occurred in 33 percent of 19,175 breaths, and was seen in every patient. The most prevalent kind of asynchrony was ineffective triggering (68%), followed by delayed termination (19%), double triggering (4%) and premature termination (3%). Asynchrony between the patient and ventilator increased considerably with decreasing levels of peak inspiratory pressure, positive end-expiratory pressure, and set frequency.Despite this, more asynchrony categories exist, and there is no widely accepted categorization. Major asynchronies, however, include auto trigger, ineffective effort, and double trigger, while minor asynchronies include early/late cycle, trigger delay, and spontaneous breaths during a mandatory breath. This study aims to compare the safety and efficacy of a closed-loop synchronization controller with conventional control of synchronization during invasive mechanical ventilation of spontaneous breathing of pediatric patients in a pediatric intensive care unit (PICU).

Eligibility

Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Pediatric patients older than 1 month and younger than18 years of age * Hospitalized at the PICU with the intention of treatment with mechanical ventilation at least for the upcoming 3 hours with spontaneous breathing activity * Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation Exclusion Criteria: * Formalized ethical decision to withhold or withdraw life support * Patient included in another interventional research study under consent * Patient already enrolled in the present study in a previous episode of respiratory failure * Pregnant woman * Patients deemed at high risk for the need of transportation from PICU to another ward, diagnostic unit or any other hospital * Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h * Not being able to obtain reference waveform

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Aydin Obstetric and pediatrics Hospital Aydin Turkey (Türkiye) Recruiting
Erzurum Regional Research and Training Hospital Erzurum Turkey (Türkiye) Recruiting
Erzurum Regional Research and Training Hospital Erzurum Turkey (Türkiye) Recruiting
Cam Sakura Research and Training Hospital Istanbul Turkey (Türkiye) Recruiting
The Health Sciences University Izmir Behçet Uz Child Health and Diseases Research and Training Hospital Izmir Turkey (Türkiye) Recruiting

More Dr. Behcet Uz Children's Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05731024 on ClinicalTrials.gov ↗ ← All trials in Turkey